Studies had shown that RIPK1 expression was significantly reduced in colon cancer tissues compared with adjacent normal colon tissues, thus impounding the cancer cell response to programmed necrosis (Moriwaki et al., 2015). This evidence concerns the gene RIPK1 and malignant colon neoplasm.